\-\ Texto\\:\\ \ \(0\)\
\-\ left\\ lower\\ extremity\\ weakness\\ noted\\.\ \(0\)\
\-\ the\\ patient\\ underwent\\ surgical\\ resection\\,\\ xrt\\,\\ and\\ chemotherapy\\.\\ \\ he\\ is\\ doing\\ well\\ 10\\ months\\ after\\ surgery\\.\\ \\ his\\ 10\\ month\\ follow\\ up\\ mri\\ exam\\ is\\ included\\ at\\ the\\ end\\ of\\ the\\ images\\ provided\\.\ \(0\)\
\-\ large\\ cystic\\/necrotic\\ mass\\ which\\ enhances\\ following\\ administration\\ of\\ gadolinium\\ in\\ the\\ right\\ frontal\\ lobe\\.\\ \\ a\\ subfalcine\\ herniation\\ is\\ evident\\,\\ with\\ mass\\ effect\\ on\\ the\\ right\\ lateral\\ ventricle\\.\\ \\ vasogenic\\ edema\\ surrounds\\ the\\ mass\\.\ \(0\)\
\-\ glioblastoma\\ multiforme\ \(8\)\
\-\ glioblastoma\\ multiforme\ \(8\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ abscess\ \(594\)\
\-\ 56\\ year\\ old\\ man\\ presented\\ with\\ headaches\\ and\\ left\\ lower\\ extremity\\ weakness\\ for\\ two\\ weeks\\.\ \(1\)\
\-\ this\\ lesion\\ has\\ an\\ appearance\\ consistent\\ with\\ gbm\\.\\ spectroscopy\\ is\\ consistent\\ with\\ a\\ tumor\\,\\ showing\\ an\\ elevated\\ choline\\ level\\ \\(indicating\\ increased\\ cellular\\ turnover\\)\\,\\ an\\ elevated\\ choline\\/creatine\\ ratio\\,\\ and\\ a\\ relative\\ decline\\ in\\ the\\ n\\-acetyl\\ \\-l\\-aspartate\\ peak\\.\\ \\ this\\ patient\\ is\\ doing\\ well\\ at\\ the\\ 10\\ month\\ point\\,\\ an\\ uncommonly\\ positive\\ response\\ to\\ treatment\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ choline\\:\\ 0\\.2790776898852634\ \(0\)\
\-\ doing\\:\\ 0\\.2184096921738109\ \(0\)\
\-\ multiforme\\:\\ 0\\.2144415042530005\ \(0\)\
\-\ glioblastoma\\:\\ 0\\.2052089273561972\ \(0\)\
\-\ 10\\:\\ 0\\.18049456706752823\ \(0\)\
\-\ the\\:\\ 0\\.16424229101933677\ \(0\)\
\-\ an\\:\\ 0\\.15737918697429112\ \(0\)\
\-\ weakness\\:\\ 0\\.15018306177971485\ \(0\)\
\-\ extremity\\:\\ 0\\.1482126530186436\ \(0\)\
\-\ is\\:\\ 0\\.14088564958351413\ \(0\)\
\-\ elevated\\:\\ 0\\.14028298802106803\ \(0\)\
\-\ turnover\\:\\ 0\\.13741438396230338\ \(0\)\
\-\ uncommonly\\:\\ 0\\.13551398885756755\ \(0\)\
\-\ subfalcine\\:\\ 0\\.13379487237450222\ \(0\)\
\-\ spectroscopy\\:\\ 0\\.13379487237450222\ \(0\)\
\-\ month\\:\\ 0\\.12517837191894102\ \(0\)\
\-\ surrounds\\:\\ 0\\.11972309705688716\ \(0\)\
\-\ decline\\:\\ 0\\.11972309705688716\ \(0\)\
\-\ cellular\\:\\ 0\\.1189867878421165\ \(0\)\
\-\ xrt\\:\\ 0\\.11827936105310183\ \(0\)\
\-\ mass\\:\\ 0\\.11790371831719976\ \(0\)\
\-\ consistent\\:\\ 0\\.11157865722375256\ \(0\)\
\-\ gbm\\:\\ 0\\.10879018251372838\ \(0\)\
\-\ peak\\:\\ 0\\.10543344247702469\ \(0\)\
\-\ lower\\:\\ 0\\.10515382116739617\ \(0\)\
\-\ ratio\\:\\ 0\\.1031958960414361\ \(0\)\
\-\ vasogenic\\:\\ 0\\.10120554029619781\ \(0\)\
\-\ well\\:\\ 0\\.09963970590461788\ \(0\)\
\-\ indicating\\:\\ 0\\.09734293781827551\ \(0\)\
\-\ 56\\:\\ 0\\.09608402670261261\ \(0\)\
\-\ response\\:\\ 0\\.09490727877560194\ \(0\)\
\-\ relative\\:\\ 0\\.09115021021199972\ \(0\)\
\-\ enhances\\:\\ 0\\.09069355111104918\ \(0\)\
\-\ end\\:\\ 0\\.09054386501521199\ \(0\)\
\-\ included\\:\\ 0\\.08897443462798385\ \(0\)\
\-\ showing\\:\\ 0\\.08883830514385627\ \(0\)\
\-\ evident\\:\\ 0\\.08843597461118059\ \(0\)\
\-\ herniation\\:\\ 0\\.0865488469370029\ \(0\)\
\-\ gadolinium\\:\\ 0\\.08573149352416287\ \(0\)\
\-\ point\\:\\ 0\\.08505922672879743\ \(0\)\
\-\ provided\\:\\ 0\\.08441111852611646\ \(0\)\
\-\ administration\\:\\ 0\\.08193641215190627\ \(0\)\
\-\ with\\:\\ 0\\.08058860579146096\ \(0\)\
\-\ at\\:\\ 0\\.07772572319212942\ \(0\)\
\-\ headaches\\:\\ 0\\.07674747017687696\ \(0\)\
\-\ ventricle\\:\\ 0\\.07573578048282627\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.07305871830815303\ \(0\)\
\-\ effect\\:\\ 0\\.07217599435035985\ \(0\)\
\-\ underwent\\:\\ 0\\.07087780322530468\ \(0\)\
\-\ this\\:\\ 0\\.07070972478909826\ \(0\)\
\-\ left\\:\\ 0\\.07019605697751542\ \(0\)\
\-\ right\\:\\ 0\\.06822459492807455\ \(0\)\
\-\ positive\\:\\ 0\\.06779923627047303\ \(0\)\
\-\ patient\\:\\ 0\\.06692991401729904\ \(0\)\
\-\ frontal\\:\\ 0\\.06622276702616803\ \(0\)\
\-\ abscess\\:\\ 0\\.06606860308741196\ \(0\)\
\-\ resection\\:\\ 0\\.06595383872761522\ \(0\)\
\-\ and\\:\\ 0\\.06378288638476762\ \(0\)\
\-\ his\\:\\ 0\\.06240031437998189\ \(0\)\
\-\ level\\:\\ 0\\.062151523248933666\ \(0\)\
\-\ appearance\\:\\ 0\\.06202840283210679\ \(0\)\
\-\ following\\:\\ 0\\.06172422916450132\ \(0\)\
\-\ weeks\\:\\ 0\\.06166400516521123\ \(0\)\
\-\ edema\\:\\ 0\\.061365864971831795\ \(0\)\
\-\ two\\:\\ 0\\.06110168833851146\ \(0\)\
\-\ he\\:\\ 0\\.060927695950440564\ \(0\)\
\-\ presented\\:\\ 0\\.059999629455666274\ \(0\)\
\-\ months\\:\\ 0\\.05989031353905568\ \(0\)\
\-\ lobe\\:\\ 0\\.05945955704257797\ \(0\)\
\-\ metastatic\\:\\ 0\\.056430026784685214\ \(0\)\
\-\ increased\\:\\ 0\\.05563802814746269\ \(0\)\
\-\ follow\\:\\ 0\\.055466653261760875\ \(0\)\
\-\ surgery\\:\\ 0\\.05531802440756582\ \(0\)\
\-\ noted\\:\\ 0\\.054552135826387724\ \(0\)\
\-\ man\\:\\ 0\\.054471251964252065\ \(0\)\
\-\ tumor\\:\\ 0\\.05381744799424484\ \(0\)\
\-\ mri\\:\\ 0\\.05281460477201333\ \(0\)\
\-\ exam\\:\\ 0\\.05179488551660559\ \(0\)\
\-\ large\\:\\ 0\\.05155300546040275\ \(0\)\
\-\ in\\:\\ 0\\.051191393552146254\ \(0\)\
\-\ lateral\\:\\ 0\\.05106205533956016\ \(0\)\
\-\ up\\:\\ 0\\.05089581387676854\ \(0\)\
\-\ surgical\\:\\ 0\\.050007904049570714\ \(0\)\
\-\ after\\:\\ 0\\.04991363342889515\ \(0\)\
\-\ lesion\\:\\ 0\\.049327762523222074\ \(0\)\
\-\ treatment\\:\\ 0\\.0490119741389871\ \(0\)\
\-\ images\\:\\ 0\\.047593482465467477\ \(0\)\
\-\ has\\:\\ 0\\.04699716134453653\ \(0\)\
\-\ which\\:\\ 0\\.0467851139820761\ \(0\)\
\-\ disease\\:\\ 0\\.04318957352017742\ \(0\)\
\-\ of\\:\\ 0\\.0402702414360683\ \(0\)\
\-\ year\\:\\ 0\\.03170867719943332\ \(0\)\
\-\ for\\:\\ 0\\.03118517420122928\ \(0\)\
\-\ on\\:\\ 0\\.031074550910402992\ \(0\)\
\-\ old\\:\\ 0\\.030451306342461036\ \(0\)\
\-\ to\\:\\ 0\\.02572230189271636\ \(0\)\
